LYELL IMMUNOPHARMA INC (LYEL) Institutional Ownership and Insiders Activity
None of the superinvestors we track currently report LYELL IMMUNOPHARMA INC (LYEL) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
Institutional Holders
0
Total Reported Value
$0
Largest Holder
—
Largest Position
—
Insider Transactions (90d)
0
Latest Filing Quarter
—
New Institutional Positions
1
Funds Exiting Positions
0
Top Institutional Owners
View allNo holder data available.
Related LYEL Institutional Insights:
- LYEL Institutional Ownership & Insiders Activity
- LYEL Institutional Ownership & 13F Activity
- LYEL Top Institutional Shareholders
- LYEL Institutional Buying Activity
- LYEL Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- LYEL Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings